Objective: This study aimed to develop an interpretable ultrasound radiomics model, using SHapley Additive exPlanations (SHAP) analysis, to predict pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients by integrating imaging features and clinical data.
Methods: A total of 131 breast cancer patients who underwent preoperative NAC were enrolled and randomly assigned to a training set (n = 91 ) and a test set (n = 40 ) at a ratio of 7:3. P re-NAC aPre-NAC treatment 2 cycles ultrasound images were collected, and radiomic features were extracted and screened from pre-treatment to post-treatment, Deand lta ((prpre-treatment-post-treatmentpre - treatment ) images. Logistic regression (LR ) was used to construct pre-treatment radiomics ( PreRad), post-treatment radiomics (PostRad), Delta radiomics ( DeltaRad ), and clinic models to predict the efficacy of NAC. The SHAP method explained the LR model by prioritizing the importance of features in terms of assessment contribution.
Results: The DltaRad model demonstrated the highest performance (among PreRad, PostRad, and DeltaRad models ), with an AUC of 0.882 in the training set and 0.758 in the test sets. The combined model, integrating DeltaRad features and clinical information, achieved an AUC of 0.951 in the training sets and 0.898 in the test sets. This model outperformed those based solely on clinical information or other radiomic features. The SHAP scatter plot illustrated that the feature’s value affected the feature’s impact attributed to the model, and the SHAP waterfall chart showed the integration of features’ impact attributed to individual response.
Conclusion: The combined model, interpreted using the SHAP method, can effectively assess pCR in breast cancer patients undergoing NAC, providing understandable guidance for personalized treatment strategies.
If you have any questions about submitting your review, please email us at [email protected].